SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-10-042410
Filing Date
2010-08-05
Accepted
2010-08-05 16:39:15
Documents
15
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a10-12904_110q.htm 10-Q 1488789
2 EX-10.2 a10-12904_1ex10d2.htm EX-10.2 21406
3 EX-10.4 a10-12904_1ex10d4.htm EX-10.4 62892
4 EX-10.5 a10-12904_1ex10d5.htm EX-10.5 49186
5 EX-31.1 a10-12904_1ex31d1.htm EX-31.1 11287
6 EX-31.2 a10-12904_1ex31d2.htm EX-31.2 11286
7 EX-32.1 a10-12904_1ex32d1.htm EX-32.1 5929
8 EX-32.2 a10-12904_1ex32d2.htm EX-32.2 6004
15 GRAPHIC g129041kgi001.jpg GRAPHIC 2415
  Complete submission text file 0001104659-10-042410.txt   4851665

Data Files

Seq Description Document Type Size
9 EX-101.INS amag-20100630.xml EX-101.INS 646088
10 EX-101.SCH amag-20100630.xsd EX-101.SCH 16952
11 EX-101.CAL amag-20100630_cal.xml EX-101.CAL 44065
12 EX-101.DEF amag-20100630_def.xml EX-101.DEF 74919
13 EX-101.LAB amag-20100630_lab.xml EX-101.LAB 203936
14 EX-101.PRE amag-20100630_pre.xml EX-101.PRE 108098
Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02140
Business Address 100 HAYDEN AVENUE LEXINGTON MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10865 | Film No.: 10994984
SIC: 2835 In Vitro & In Vivo Diagnostic Substances